The Diabetic Kidney Disease market report covers emerging drugs, current treatment practices, market share of the individual therapies, current and forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market.
Diabetic Kidney Disease: An Overview
According to the National Institute of Diabetes and Digestive and Kidney Disease, Diabetic Kidney Disease is a type of kidney disease caused by diabetes, when high blood glucose initiates to damage the blood vessels in kidneys and creates problems in its functioning. Diabetic kidney disease is also called chronic kidney disease, CKD, kidney disease of diabetes, or diabetic nephropathy.
Diabetic Kidney Disease Market Key Facts
-
According to the National Institute of Diabetes and Digestive and Kidney Disease, diabetes is the leading cause of kidney disease and about one out of four adults with diabetes have kidney disease.
-
As per the study by Alicic et al., diabetic kidney disease develops in approximately 40% of patients who are diabetic and is the leading cause of CKD worldwide. The kidney disease attributed to diabetes is a major but under-recognized contributor to the global burden of disease. Between 1990 and 2012, the number of deaths attributed to DKD rose by 94%.
-
As per the study by Duru et al., approximately 25% of individuals with diabetes have diabetic kidney disease (DKD), which refers to CKD presumed to be caused by diabetes. In the United States, the prevalence of DKD will likely increase owing to a projected 54% increase in the prevalence of diabetes by 2030.
Diabetic Kidney Disease Market
As per DelveInsight, the Diabetic Kidney Disease market is expected to increase during the forecast period owing to the launch of upcoming therapies, increasing awareness, the introduction of novel drugs, incremental healthcare spending across the world, and the changing lifestyle.
The market outlook section of the report helps to build a detailed comprehension of the historic, current, and forecasted Diabetic Kidney Disease market size by analyzing the impact of current and emerging therapies in the market. It also provides a detailed assessment of the market drivers & barriers, unmet needs, and emerging technologies.
The report gives a thorough detail of the Diabetic Kidney Disease market trend for each marketed drug and late-stage pipeline therapies by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action (MoA), competition with other therapies, brand value, their impact on the market and view of the key opinion leaders.
Diabetic Kidney Disease Epidemiology
The epidemiology section covers insights about the historical and current Diabetic Kidney Disease patient pool and forecasted trends for every seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool and their trends along with assumptions undertaken.
Diabetic Kidney Disease Epidemiology Segmentation
-
Prevalent Population of Diabetic Kidney Disease
-
Diagnosed cases of Diabetic Kidney Disease
-
Treatable Cases of Diabetic Kidney Disease
Diabetic Kidney Disease Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Diabetic Kidney Disease market or expected to get launched in the market during the study period. The analysis covers Diabetic Kidney Disease market uptake by drugs; patient uptake by therapies; and sales of each drug.
Report’s Drugs Uptake section helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.
The report also covers the Diabetic Kidney Disease Pipeline Development Activities and provides valuable insights about different therapeutic candidates in Phase II, and Phase III stages and the key companies in the market involved in developing targeted therapeutics. It also analyses the recent Development such as collaborations, acquisitions, and mergers, licensing patent details, and other information for emerging therapies.
Get the PDF Sample of the Report:- https://www.delveinsight.com/sample-request/diabetic-kidney-disease-dkd-market
Diabetic Kidney Disease Therapeutics Analysis
Globally, several companies are involved in the development of novel therapies for Diabetic Kidney Disease, the launch of the therapies is expected to create a significant shift in the treatment scenario.
Some of the key companies in the Diabetic Kidney Disease Market include:
-
Orbsen Therapeutics
-
Bayer
-
Reata Pharmaceuticals
-
Novartis
-
Dimerix
-
Kyowa Kirin
-
Gilead Science
And many others
Diabetic Kidney Disease Therapies covered in the report includes:
-
Selonsertib
-
ORBCEL-M
-
Finerenone
-
Bardoxolone methyl
-
LMB763
-
DMX-200
-
Bardoxolone methyl
-
Selonsertib (SEL)
And many more
Get More Detailed Insights into the Emerging Therapies & Key Companies:- https://www.delveinsight.com/sample-request/diabetic-kidney-disease-dkd-market
Table of Content
1. Key Insights
2. Executive Summary
3. Diabetic Kidney Disease Competitive Intelligence Analysis
4. Diabetic Kidney Disease Market Overview at a Glance
5. Diabetic Kidney Disease Disease Background and Overview
6. Diabetic Kidney Disease Patient Journey
7. Diabetic Kidney Disease Epidemiology and Patient Population
8. Diabetic Kidney Disease Treatment Algorithm, Current Treatment, and Medical Practices
9. Diabetic Kidney Disease Unmet Needs
10. Key Endpoints of Diabetic Kidney Disease Treatment
11. Diabetic Kidney Disease Marketed Products
12. Diabetic Kidney Disease Emerging Therapies
13. Diabetic Kidney Disease Seven Major Market Analysis
14. Attribute Analysis
15. Diabetic Kidney Disease Market Outlook (7 major markets)
16. Diabetic Kidney Disease Access and Reimbursement Overview
17. KOL Views on the Diabetic Kidney Disease Market.
18. Diabetic Kidney Disease Market Drivers
19. Diabetic Kidney Disease Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
*The table of contents is not exhaustive; the final content may vary.
Request Sample Report here:- https://www.delveinsight.com/sample-request/diabetic-kidney-disease-dkd-market
Other Trending Healthcare Reports By DelveInsight
Malignant Pleural Mesothelioma (MPM) Market
Malignant Pleural Mesothelioma (MPM) Market is anticipated to grow in the coming years owing to the improvement in healthcare spending across the world, rising prevalence, and the active participation of the key companies in the therapeutics domain such as Sellas, Polaris Pharma, Targovax, among others.
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Shruti Thakur
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/
